文献速递心脑血管急症

院前HEART评分在疑似心肌梗死患者中的表现:一项前瞻性评估

Performance of a prehospital HEART score in patients with possible myocardial infarction: a prospective evaluation.
PubMed 文献 · Emerg Med J · 2023-06-02
一句话结论院前由急救人员计算的HEART评分≤3分(即使采用高敏肌钙蛋白检测限改良)不能安全排除心肌梗死,≥7分也不优于单纯肌钙蛋白检测。

本研究为前瞻性队列研究的预设二次分析,2014年11月至2018年4月由急救人员纳入疑似心肌梗死患者1054例,960例纳入分析(平均64岁,42%女性),30天主要不良心脏事件(MACE)发生255例(26%)。HEART评分≤3分将279例(29%)归为低危,阴性预测值:当代检测法93.5%(95%CI 90.0%~95.9%),高敏检测法91.4%(95%CI 87.5%~94.2%);采用高敏检测法检测限的改良HEART评分≤3分将194例(20%)归为低危,阴性预测值95.9%(95%CI 92.1%~97.9%)。HEART评分≥7分(任一检测法)的阳性预测值低于单独使用任一肌钙蛋白检测法上限参考值。结论:院前HEART评分不能安全排除心肌梗死,与单独肌钙蛋白检测相比也无增强的rule-in价值。

要点

  • 院前HEART评分≤3分(当代检测法)阴性预测值93.5%(95%CI 90.0%~95.9%),未能安全排除30天MACE。
  • 高敏检测法HEART评分≤3分阴性预测值91.4%(95%CI 87.5%~94.2%),仍不能安全排除。
  • 采用高敏检测法检测限的改良HEART评分≤3分阴性预测值95.9%(95%CI 92.1%~97.9%),仅识别20%低危患者。
  • HEART评分≥7分(任一检测法)阳性预测值低于单独使用任一肌钙蛋白检测法上限参考值。
  • 院前HEART评分不能安全排除心肌梗死,也不优于单独肌钙蛋白检测。

适用人群与场景

  • 由急救人员纳入的疑似心肌梗死患者,共1054例,其中960例纳入分析(平均64岁,SD 15岁,42%女性)。

诊断标准与关键阈值

  • HEART评分≤3分定义为低危,≥7分定义为高危。
  • 改良HEART评分采用高敏肌钙蛋白检测法的检测限。

研究设计与关键结果

  • 研究类型:前瞻性队列研究的预设二次分析;2014年11月至2018年4月招募1054例,960例纳入分析;255例(26%)在30天发生MACE。
  • HEART评分≤3分(当代检测法)识别279例(29%)低危,阴性预测值93.5%(95%CI 90.0%~95.9%);高敏检测法阴性预测值91.4%(95%CI 87.5%~94.2%)。
  • 采用高敏检测法检测限的改良HEART评分≤3分识别194例(20%)低危,阴性预测值95.9%(95%CI 92.1%~97.9%)。
  • HEART评分≥7分(任一检测法)的阳性预测值低于单独使用任一肌钙蛋白检测法上限参考值。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究的预设二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 院前由急救人员计算的HEART评分(即使采用高敏检测法改良)不能安全排除心肌梗死,与单独肌钙蛋白检测相比也无增强的rule-in价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The History, Electrocardiogram (ECG), Age, Risk Factors and Troponin (HEART) score is commonly used to risk stratify patients with possible myocardial infarction as low risk or high risk in the Emergency Department (ED). Whether the HEART score can be used by paramedics to guide care were high-sensitivity cardiac troponin testing available in a prehospital setting is uncertain.

METHODS: In a prespecified secondary analysis of a prospective cohort study where paramedics enrolled patients with suspected myocardial infarction, a paramedic Heart, ECG, Age, Risk Factors (HEAR) score was recorded contemporaneously, and a prehospital blood sample was obtained for subsequent cardiac troponin testing. HEART and modified HEART scores were derived using laboratory contemporary and high-sensitivity cardiac troponin I assays. HEART and modified HEART scores of ≤3 and ≥7 were applied to define low-risk and high-risk patients, and performance was evaluated for an outcome of major adverse cardiac events (MACEs) at 30 days.

RESULTS: Between November 2014 and April 2018, 1054 patients were recruited, of whom 960 (mean 64 (SD 15) years, 42% women) were eligible for analysis and 255 (26%) experienced a MACE at 30 days. A HEART score of ≤3 identified 279 (29%) as low risk with a negative predictive value of 93.5% (95% CI 90.0% to 95.9%) for the contemporary assay and 91.4% (95% CI 87.5% to 94.2%) for the high-sensitivity assay. A modified HEART score of ≤3 using the limit of detection of the high-sensitivity assay identified 194 (20%) patients as low risk with a negative predictive value of 95.9% (95% CI 92.1% to 97.9%). A HEART score of ≥7 using either assay gave a lower positive predictive value than using the upper reference limit of either cardiac troponin assay alone.

CONCLUSIONS: A HEART score derived by paramedics in the prehospital setting, even when modified to harness the precision of a high-sensitivity assay, does not allow safe rule-out of myocardial infarction or enhanced rule-in compared with cardiac troponin testing alone.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Cooper JG, Ferguson J, Donaldson LA, et al. Performance of a prehospital HEART score in patients with possible myocardial infarction: a prospective evaluation. Emerg Med J. 2023. PMID: 37268413. doi:10.1136/emermed-2022-213003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。